PAH diagnosis and management in the context of CTD ILD Pulmonary arterial hypertension (PAH) is a serious complication https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… […]
QD Clinic Video: RA and Bronchiectasis Dr. Jeffrey Sparks, Boston, talks about rheumatoid arthritis and bronchiectasis https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Fri, 09/12/2025
TNR: Future Treatment of ILD This Tuesday Night Rheumatology webinar reviewed ACR and EULAR guidelines on interstitial https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Fri,
STOP-RA results published in A&R. 144 at risk, CCP+ pts were enrolled to received HCQ vs PBO for 12 mos,
AbbVie’s US patent protection for Rinvoq (upadacitinib) will run till April 2037. SEC filing shows AbbVie has reached an https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
Antifibrotics – A New Class of Therapies in Rheumatology? Rheumatologists typically manage systemic autoimmune rheumat https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Fri, 09/12/2025 –
QD Clinic: Beyond the Numbers in Newly Diagnosed ILD tammytilley@gm… Fri, 09/12/2025 – 11:41 Education/ACR/EULAR Rheumatoid Arthritis Cardio/Pulmonary Labs/Biomarkers Outcomes
9 yr. study of anti-Ro52 & ILD pts — 1,026 pts 15% Ro52+: interstitial pneumonia w/ autoimmune 48%, CTD-ILD 13%,
In #scleroderma pts with cardiac involvement, the presence of ventricular ectopy is assocd w/ ⬆️risk of mortality &a https://pbs.twimg.com/profile_images/1027501556868870145/2culK0bN_normal.jpg john+RNV2@john…
Flow cytometry on Peripheral blood can help patient stratification in RA A cluster rich in TEMRA Terminally Differentia https://pbs.twimg.com/profile_images/1800478984926334976/yyyPLP4A_normal.jpg john+RNV2@john…
2025 Update of EULAR RA management recommandation Summary slide inspired from Josef Smolen’s presentation @RheumNow https://pbs.twimg.com/profile_images/1800478984926334976/yyyPLP4A_normal.jpg john+RNV2@john… Fri, 09/12/2025 –
Is it #lupus? Interesting study by @escheriKYA et al. showing comparable diagnostic performance of SLERPI (93%) in 🇵 https://pbs.twimg.com/profile_images/1027501556868870145/2culK0bN_normal.jpg john+RNV2@john…
Remember! ☝️ Trabecular bone screening should not be routinely used in pre-menopausal women. @RheumNow #APLAR25 #os https://pbs.twimg.com/profile_images/1027501556868870145/2culK0bN_normal.jpg john+RNV2@john… Fri, 09/12/2025
Key takeaways of trabecular bone screening: 📌Complements but doesnt replace BMD/FRAX in fracture risk assessment ? https://pbs.twimg.com/profile_images/1027501556868870145/2culK0bN_normal.jpg john+RNV2@john… Fri, 09/12/2025
Cross-sectional study of 320 dermatomyositis (198 classic DM, 122 amyopathic DM/CADM) & compared myositis panels for https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Fri, 09/12/2025
RheumNow Podcast – Ro, Ro, Ro52 (9.12.2025) jjcush@gmail.com Fri, 09/12/2025 – 07:00
Ro, Ro, Ro52 (9.12.2025) jjcush@gmail.com Fri, 09/12/2025 – 00:16 Education/ACR/EULAR Anti-Rheumatic Rx Drug Safety Fibromyalgia/Pain Rheumatoid Arthritis Cardio/Pulmonary Dermatology Eye
Japanese retrospective real world study shows antifibrotic use assoc w/ better survival in Pulm Fibrosis-ILD for 1st 3 https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
3 yr study of FDA Adverse Event Reporting on anifrolumab shows following AEs- URIs, herpes zoster, infusion reactions, https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
SMART study – Single vs. Split Dose Methotrexate in RA jjcush@gmail.com Thu, 09/11/2025 – 17:20
Sjogren’s Disease Interstitial Lung Disease Dr. Nancy Carteron, a rheumatologist in northern California, discusses int https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Thu, 09/11/2025 –
How to assess ILD in your patients? Janet.Pope@sjh… Thu, 09/11/2025 – 15:46
Single center study of 47 RA-ILD pts (Dx Age 64.7 yrs; 30 mos F/U). Median 100 mos from RA Dx
Italian Systemic sclerosis (SPRING-SIR) registry – 1157/1538 (75%) SSc pts were in menopause, 632 (50%) had pre-menop SS https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
Regional Disparities in DMARD Management for RA Treatment Dr. Aurelie Najm, Glasgow, reports on a session on “Updates https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
QD Clinic: Progressive RA-ILD Management tammytilley@gm… Thu, 09/11/2025 – 14:46 Rheumatoid Arthritis Anti-Rheumatic Rx Drug Safety Novel Rx TNF inhibitor
